A Multidisciplinary Perspective on Semaglutide Treatment and Medical Nutrition Therapy in Obesity Management

Oct 23, 2025Current obesity reports

Combining Semaglutide Medication and Nutrition Therapy for Managing Obesity

AI simplified

GLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

, a glucagon-like peptide-1 receptor agonist, promotes significant weight loss and metabolic improvement.

Combining semaglutide with tailored nutritional interventions may enhance weight loss outcomes.
The Mediterranean diet supports gradual weight loss and reduces inflammation for individuals with uncomplicated obesity.
may offer rapid fat loss and improved blood sugar control for patients with cardiometabolic issues.
Integrated dietary strategies with semaglutide could preserve lean body mass and reduce gastrointestinal side effects.
Personalized nutrition plans based on individual metabolic and hormonal profiles may optimize treatment effectiveness.

AI simplified

PURPOSE OF REVIEW: This review explores the integration of , a highly effective glucagon-like peptide-1 receptor agonist (GLP-1RA), with (MNT) for the comprehensive management of obesity. Semaglutide promotes significant weight loss and metabolic improvement, but optimal outcomes often require combining this pharmacological treatment with tailored nutritional interventions. This review focuses on two prominent dietary strategies whose nutritional profiles may complement semaglutide's mechanisms of action: the Mediterranean diet (MD) and (VLEKT).

RECENT FINDINGS: The MD emphasises balanced macronutrients and anti-inflammatory components, making it particularly suitable for individuals with uncomplicated obesity; it supports gradual and sustainable weight loss while mitigating inflammation and gastrointestinal side effects. Conversely, VLEKT, which induces nutritional ketosis, may be more appropriate for patients with significant cardiometabolic comorbidities, offering rapid and substantial fat mass reduction and improved glycaemic control. Both dietary approaches, when integrated with semaglutide therapy, have the potential to preserve lean body mass, reduce gastrointestinal adverse events, and enhance adherence through improved satiety and tolerability. The proposed integrated approach underscores the importance of personalised nutritional strategies guided by patient-specific metabolic, hormonal, and microbiota profiles, and calls for effective multidisciplinary collaboration among nutritionists, endocrinologists, and behavioural health professionals to optimise therapeutic outcomes. Ultimately, we emphasise that shifting the clinical focus from weight reduction alone to a targeted approach integrating semaglutide with evidence-based nutritional strategies may represent the most promising pathway towards sustainable obesity management.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text (PDF) ↗View full text (HTML) ↗

A Multidisciplinary Perspective on Semaglutide Treatment and Medical Nutrition Therapy in Obesity Management

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief